There is a trend of microdosing semaglutide, also known as GLP-1 drugs, for weight loss, with various outlets exploring its effectiveness and risks. Some medical professionals have expressed concerns about this practice, while others are examining its potential benefits. The efficacy and safety of microdosing GLP-1s for weight loss appear to be uncertain and under debate among experts.